Loading…
Securing drug patents, managing clinical trial compliance, and telehealth legal risks.
0+
Pharmaceutical formulations and biosimilar patents filed
0%
CDSCO compliance audit success rate
0+
Clinical trial agreements and site contracts drafted
0M+
Patient health data records secured under privacy frameworks
Pharma, biotech, and healthcare organizations operate in a highly technical and strictly monitored compliance ecosystem. From ensuring drug patent protection and managing clinical trial agreements to securing health data on telehealth platforms, these operations demand precise legal oversight. We help healthcare organizations file patents, draft clinical trial agreements, manage CDSCO registrations, and secure medical data systems.
These are the most critical areas where businesses in the healthcare & life sciences sector face legal exposure:
Overcoming Section 3(d) patent rejections on incremental drug discoveries by proving enhanced efficacy is a primary challenge for pharmaceutical R&D.
Failing to draft balanced Clinical Trial Agreements (CTA) with clear injury compensation, investigator duties, and IP assignment clauses can lead to severe litigation.
Digital health apps collecting electronic health records (EHR) face high liability under the DPDP Act 2023 for any unauthorized access to patient data.
Violating the Drugs and Cosmetics Act rules regarding drug descriptions, manufacturing declarations, and warning labels can result in product recall orders.
Unaddressed, these risk factors can lead to revenue loss, regulatory penalties, or competitive disadvantage:
Our structured engagement model ensures nothing falls through the cracks:
Analyze formulations against Section 3(d) and file patent applications globally.
Draft and review site agreements, investigator forms, and patient consent documentation.
Implement data encryption policies and DPDP compliant consent logs for telehealth apps.
Guide your business through drug licensing applications and labeling compliance audits.
Draft non-disclosure and trade secret agreements with formulation labs and research staff.
Businesses in the healthcare & life sciences sector must align operations with these key Indian statutes and regulatory standards:
We recommend implementing these key protective legal and IP measures early:
Section 3(d) prevents the 'evergreening' of patents. It states that a mere discovery of a new form of a known substance which does not result in the enhancement of the known efficacy is not patentable.
Software that processes diagnostic data can be protected as copyright (for source code) and potentially patented if it interfaces with diagnostic hardware to achieve a new technical effect.
Implement end-to-end encryption, define granular user consent flows under the DPDP Act, and store data within compliant local hosting servers.
Yes, under the Telemedicine Practice Guidelines 2020, registered medical practitioners can prescribe medicines remotely, provided they follow the designated consult and consent protocols.
Operating an e-pharmacy without regulatory approvals can lead to show-cause notices from state drug controllers, product supply bans, and director prosecution under the Drugs & Cosmetics Act.
A Clinical Trial Agreement must cover: study protocols, patient safety policies, data confidentiality, intellectual property ownership, indemnification, and trial funding schedules.